Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Pancreatitis Disease Market Insights: Epidemiology Study, Drug Development, Clinical Trial and Price Reimbursement | Disease Landscape Insights

This image opens in the lightbox

News provided by

Disease Landscape Insights

12 Oct, 2023, 16:45 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Oct. 12, 2023 /PRNewswire/ -- Pancreatitis is type of gastrointestinal disorder leading to the inflammation of the pancreas. Health complications of pancreatis can become very severe if not diagnosed and treated on time. According to an epidemiology study by the NIH the present overall incidence of acute pancreatitis, based on the 10 589 cases, is 30.0 per 100 000 population and the mortality rates at 30 days and 60 days were 5.6% and 6.4% respectively (based on 560 and 675 deaths).  This growing disease burden is indeed a matter of concern for numerous nations.


Pancreas is a gland located behind the stomach which is responsible for digestion and blood sugar levels regulation. It produces vital enzymes and hormones like insulin. Pancreatitis is caused when this organ becomes inflamed, leading to severe consequences. The primary types of this ailment are-

  • Chronic pancreatitis
  • Acute pancreatitis
  • Autoimmune pancreatitis
  • Hereditary pancreatitis

Price and Market Access

The Market Competitors Listed Below are Revolutionizing Healthcare with Innovative Diagnostic Inventions:

  • Cook Medical Incorporated
  • Olympus Corporation
  • FujiFilm Corporation
  • IDEXX Laboratories, Inc.
  • Roche Diagnostics
  • Bio-Rad Laboratories
  • Canon Medical System Corporation
  • Siemens Healthineers
  • GE Healthcare
  • Philips
  • Neusoft Medical System
  • United Imaging Healthcare
  • Others

Apart from that, hyperglycemia pancreatitis, gallstone pancreatitis, and alcoholic pancreatitis are some of the sub types of this severe ailment.

Causes And Symptoms of This Ailment:

There are numerous causes of pancreatitis including excessive alcohol intake, improper diet, trauma injuries to the pancreas, medicine side effects, and pancreatic surgery that might have been performed to remove a tumor. This ailment can occur in any age group although the geriatric population is a highly vulnerable group.

The major symptoms of pancreatitis include abdominal pain, weight loss, drainage of pancreatic fluid, fever, vomiting, nausea, and diarrhoea, among others. In severe cases it may lead to the onset of pancreatic cancer, pancreatic abscess, and pancreatic fistula.

Role of DLI in Pancreatitis Disease Management:

The growing pervasiveness of this disorder has created an immediate need for effective diagnostic and treatment. Industry participants are seeking assistance from DiseaseLandscape Insights to accelerated their R&D process. This health consultant has been supporting them with clinical trial feasibility analysis, clinical trial management, commercial strategy analysis, price and market access strategies along with product portfolio extension and product pipeline analysis, among others. They players are also leveraging DLI's new product development services, regulatory consulting, product launch services, pharma consulting services, and post launch services.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @https://www.diseaselandscape.com/downloadsample/postid/92

Diagnostic And Treatment Landscape:

Diagnosis of pancreatitis involves a series of physical and biological tests. The primary ones include medical history and physical examination, blood tests, imaging tests like endoscopy and MRI, along with endoscopic tests, among others. Early detection paves the way for fast prognosis which in turn paves the way for effective treatment planning.

The treatment of pancreatitis is strategized depending on the severity, underlying cause, and presence of complications. Treatment goals include relieving symptoms, managing complications, and addressing the underlying cause. Drugs with FDA EMA approved indications are prescribed to alleviate many associated symptoms. Besides, fluid replacement, lifestyle modifications, nutritional support, and other sort of supportive care are some of the other treatment solutions of inflammation pancreases.

The prevention of pancreatitis can be promoted by making dietary changes, avoiding alcohol, regular exercise, discontinuing medications with prolonged side effects, and other lifestyle changes.

Unlock the Benefits Today! Get Started Now and Elevate Your Experience @
https://www.diseaselandscape.com/checkout?report_id=92

Final Words:

Pancreatitis, marked by inflammation of the pancreas with significant implications for digestion and blood sugar regulation, necessitates a comprehensive approach for understanding and addressing the disease landscape. DLI helps Pancreatitis Disease Market players in identifying critical treatment gaps within the current medical landscape, offering guidance for pharmaceutical companies seeking to develop novel therapies, and meticulously assessing ongoing clinical trials to ensure they align with patient needs and scientific advancements. By providing these insights and fostering collaboration between stakeholders, DLI contributes significantly to the enhancement of pancreatitis care, potentially leading to improved patient outcomes and a brighter future in managing this complex condition.

Browse Through More Gastrointestinal Disease Research Reports

Related Reports:

Launch of a Medical High Tech Innovation Case Study

Case Analysis: Development of an Antibiotic

Case Study: Using Emerging Technologies to Discover Antiallergic Drugs

Case Study: Creation and Submission of a New Drug Application (NDA)

Case Study: Trends in API Prices

Collaboration with Commercial Laboratories to Develop Monkeypox Detection Technologies to Support Business Growth

For lung cancer treatment, radiation is employed.

Immunomodulating Drugs for Lupus

To Launch More Affordable Drugs and Boost Productivity Through Cost-Effective Research and Development

Finding a Hemophilia Treatment Facility that Accepts

Launch of a Pneumonia Diagnostic Tool in the Market

Examining the Impact of AI on Radiology: AI Applications in Medical Imaging

Addressing Ethical Considerations in AI Healthcare: Insights and Strategies

Top cancer-related causes of death

Paxlovid is recognized as a COVID-19 Breakthrough Therapy with Emergency Use Authorization.

The Top 5 Monkeypox Research Companies and Monkeypox

How Technology is Revolutionizing the Entire Drug Discovery Sector: The Power of Tech Innovation

Fighting Lung Cancer: Causes, Treatment, Research, and Leading Companies

Money Is Important: Boosting Clinical Trial Revenue Strategies by Resolving CRO Issues

Miebo: A Hopeful New Method for Treating Dry Eye Disease

Qalsody: A Revolutionary Drug from Biogen Inc.

Contact Us: 

Disease Landscape Insights LLP 
6th Floor, Sr No.207, Office A H 6070 Phase 1 
Solitaire Business Hub, Viman Nagar 
Pune, Maharashtra, 411014.
Sales Contact: +44-2038074155 
Asia Office Contact: +917447409162
Email: ajay@diseaselandscape.com
Email: vishal@diseaselandscape.com
Blog: https://www.diseaselandscape.com/blogs
Case Study: https://www.diseaselandscape.com/casestudies    
Pharma consulting Services 
Follow Us: LinkedIn | Twitter | Facebook

Logo: https://mma.prnewswire.com/media/2217060/Disease_Landscape_Insights_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.